Key result
HFE C282Y and H63D mutations are linked to increased CAD risk in type 2 diabetes.
Why the study?
Diabetes mellitus is a risk factor for cardiovascular diseases, and the association of HFE gene mutations with increased CAD risk in T2D patients was unclear.
Are C282Y and H63D mutations in the HFE gene associated with an increased risk of coronary artery disease in patients with type 2 diabetes?
Case-Control (n=290)
Are C282Y and H63D mutations in the HFE gene associated with an increased risk of coronary artery disease in patients with type 2 diabetes?
p-value: p=< 0.05
C282Y and H63D mutations in the HFE gene are significantly correlated with the development of coronary artery disease in patients with type 2 diabetes.
BACKGROUND/AIM: Diabetes mellitus is a risk factor for cardiovascular diseases (CVDs), which are among the major causes of deaths in type 2 diabetes (T2D). The purpose of the present study was to determine the association of C282Y and H63D mutations in the HFE gene with increased risk of coronary artery disease (CAD) in T2D patients. MATERIALS AND METHODS: Two hundred and ninety individuals were divided into two groups: a case group and a control group. Genomic DNA of peripheral venous blood cells was extracted and the HFE gene mutations were analyzed using the PCR-RFLP technique. RESULTS: Data analysis revealed a significant difference between the allele frequencies of H63D and C282Y mutations between the case group and the controls (P < 0.05). The relationships between the GA and GG genotypes in C282Y and H63D mutations in terms of fasting blood sugar (FBS), lipid profile (total cholesterol, triglycerides, high-density lipoproteins (HDL), low-density lipoproteins), body mass index (BMI), HbA1c, micro albuminuria, and creatine levels did not show a significant differences between the two groups (P > 0.05). Using a logistic regression model, BMI, FBS, HDL, and total cholesterol levels were significantly different with independent predictors of CVD (P < 0.05). CONCLUSION: Our results revealed a significant correlation between C282Y and H63D mutations and the development of CAD in T2D patients.
No takes yet. Share an insight, caveat, or question.
Saremi et al. (2016) conducted a case-control in Type 2 diabetes and coronary artery disease (n=290). C282Y and H63D mutations in the HFE gene vs. Control group was evaluated on Difference in allele frequencies of H63D and C282Y mutations between cases and controls (p=< 0.05). C282Y and H63D mutations in the HFE gene were significantly associated with an increased risk of coronary artery disease among patients with type 2 diabetes (P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: